PRAZOSIN LONG-TERM TREATMENT IN SEVERE CHRONIC CARDIAC-FAILURE

被引:4
作者
KUCK, KH
HANRATH, P
ZEHNKE, A
MATHEY, D
BLEIFELD, W
机构
关键词
D O I
10.1055/s-2008-1070876
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1384 / 1388
页数:5
相关论文
共 25 条
[1]   EFFICACY OF TRIMAZOSIN AND PRAZOSIN THERAPY ON CARDIAC AND EXERCISE PERFORMANCE IN OUTPATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
ARONOW, WS ;
DANAHY, DT .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (01) :155-160
[2]  
AWAN NA, 1977, CLIN PHARMACOL THER, V22, P79
[3]   COMPARISON OF EFFECTS OF NITROPRUSSIDE AND PRAZOSIN ON LEFT-VENTRICULAR FUNCTION AND PERIPHERAL-CIRCULATION IN CHRONIC REFRACTORY CONGESTIVE HEART-FAILURE [J].
AWAN, NA ;
MILLER, RR ;
MASON, DT .
CIRCULATION, 1978, 57 (01) :152-159
[4]   EFFICACY OF AMBULATORY SYSTEMIC VASODILATOR THERAPY WITH ORAL PRAZOSIN IN CHRONIC REFRACTORY HEART-FAILURE - CONCOMITANT RELIEF OF PULMONARY CONGESTION AND ELEVATION OF PUMP OUTPUT DEMONSTRATED BY IMPROVEMENTS IN SYMPTOMATOLOGY, EXERCISE TOLERANCE, HEMODYNAMICS AND ECHOCARDIOGRAPHY [J].
AWAN, NA ;
MILLER, RR ;
DEMARIA, AN ;
MAXWELL, KS ;
NEUMANN, A ;
MASON, DT .
CIRCULATION, 1977, 56 (03) :346-354
[5]   DEVELOPMENT OF SYSTEMIC VASODILATOR TOLERANCE TO PRAZOSIN WITH CHRONIC USE OF AGENT IN AMBULATORY THERAPY OF SEVERE CONGESTIVE HEART-FAILURE [J].
AWAN, NA ;
MILLER, RR ;
MAXWELL, KS ;
MASON, DT .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (02) :367-367
[6]   CLINICAL PHARMACOLOGY AND THERAPEUTIC APPLICATION OF PRAZOSIN IN ACUTE AND CHRONIC REFRACTORY CONGESTIVE HEART-FAILURE - BALANCED SYSTEMIC VENOUS AND ARTERIAL DILATION IMPROVING PULMONARY CONGESTION AND CARDIAC-OUTPUT [J].
AWAN, NA ;
MILLER, RR ;
MILLER, MP ;
SPECHT, K ;
VERA, Z ;
MASON, DT .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (01) :146-154
[7]  
CAMBRIDGE D, 1977, BRIT J PHARMACOL, V59, P514
[8]  
CAMBRIDGE D, 1977, MED J AUST S2, P2
[9]  
Constantine J. W., 1973, HYPERTENSION MECHANI, P429
[10]   PRAZOSIN AND PRESYNAPTIC ALPHA-RECEPTORS IN CARDIO ACCELERATOR NERVE OF DOG [J].
CONSTANTINE, JW ;
WEEKS, RA ;
MCSHANE, WK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 50 (01) :51-60